Symbol | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
LH | CEO, Covance Drug Development | May 19, 2023 |
Option Exercise | $182.51 | 4,300 | 784,793 | 17,246 | May 23, 2023, 08:06 AM |
LH | CEO, Covance Drug Development | May 19, 2023 |
Sale | $216.91 | 4,300 | 932,707 | 12,946 | May 23, 2023, 08:06 AM |
LH | CEO, Covance Drug Development | Mar 30, 2023 |
Option Exercise | $224.70 | 2,886 | 648,484 | 12,946 | Apr 03, 2023, 10:13 AM |
LH | CEO, Covance Drug Development | Feb 21, 2023 |
Option Exercise | $182.51 | 3,000 | 547,530 | 17,069 | Feb 23, 2023, 09:54 AM |
LH | CEO, Covance Drug Development | Feb 21, 2023 |
Sale | $250.58 | 8,000 | 2,004,675 | 9,069 | Feb 23, 2023, 09:54 AM |
LH | CEO, Covance Drug Development | Feb 13, 2023 |
Option Exercise | $248.13 | 142 | 35,234 | 14,069 | Feb 14, 2023, 02:57 PM |
LH | CEO, Covance Drug Development | Feb 06, 2023 |
Option Exercise | $244.50 | 164 | 40,098 | 13,728 | Feb 07, 2023, 02:51 PM |
LH | CEO, Covance Drug Development | Feb 02, 2023 |
Option Exercise | $254.99 | 141 | 35,954 | 13,332 | Feb 06, 2023, 03:45 PM |
LH | CEO, Covance Drug Development | Nov 01, 2022 |
Option Exercise | $222.56 | 892 | 198,524 | 13,030 | Nov 03, 2022, 05:00 PM |
LH | CEO, Covance Drug Development | Mar 28, 2022 |
Option Exercise | $276.42 | 1,648 | 455,540 | 11,915 | Mar 29, 2022, 12:04 PM |
LH | CEO, Covance Drug Development | Feb 14, 2022 |
Option Exercise | $272.68 | 108 | 29,449 | 9,856 | Feb 15, 2022, 04:42 PM |
LH | CEO, Covance Drug Development | Feb 04, 2022 |
Option Exercise | $277.48 | 165 | 45,784 | 9,647 | Feb 08, 2022, 11:13 AM |
LH | CEO, Covance Drug Development | Feb 02, 2022 |
Option Exercise | $273.18 | 144 | 39,338 | 9,252 | Feb 04, 2022, 09:44 AM |
LH | CEO, Covance Drug Development | Nov 01, 2021 |
Option Exercise | $288.78 | 898 | 259,324 | 8,953 | Nov 03, 2021, 11:47 AM |
LH | CEO, Covance Drug Development | Apr 03, 2021 |
Option Exercise | $252.67 | 452 | 114,207 | 10,344 | Apr 06, 2021, 12:18 PM |
LH | CEO, Covance Drug Development | Mar 27, 2021 |
Option Exercise | $251.58 | 790 | 198,748 | 9,786 | Mar 30, 2021, 06:42 PM |
LH | CEO, Covance Drug Development | Feb 12, 2021 |
Option Exercise | $238.26 | 180 | 42,887 | 8,472 | Feb 17, 2021, 04:25 PM |
LH | CEO, Covance Drug Development | Feb 04, 2021 |
Option Exercise | $223.78 | 187 | 41,847 | 8,071 | Feb 08, 2021, 03:39 PM |
LH | CEO, Covance Drug Development | Nov 04, 2020 |
Sale | $214.14 | 1,500 | 321,204 | 7,698 | Nov 06, 2020, 09:06 AM |
LH | CEO, Covance Drug Development | Nov 02, 2020 |
Option Exercise | $207.23 | 895 | 185,471 | 9,198 | Nov 04, 2020, 05:40 PM |
LH | CEO, Covance Drug Development | Apr 03, 2020 |
Option Exercise | $113.31 | 372 | 42,151 | 8,087 | Apr 07, 2020, 04:21 PM |
LH | CEO, Covance Drug Development | Mar 30, 2020 |
Option Exercise | $131.95 | 1,014 | 133,797 | 7,449 | Apr 01, 2020, 02:29 PM |
LH | CEO, Covance Drug Development | Feb 12, 2020 |
Option Exercise | $187.51 | 159 | 29,814 | 5,061 | Feb 14, 2020, 03:48 PM |
LH | CEO, Covance Drug Development | Feb 07, 2020 |
Option Exercise | $182.33 | 103 | 18,780 | 4,641 | Feb 11, 2020, 01:43 PM |
Symbol | Relationship | Date | Transaction | Value($) |
LH | CEO, Covance Drug Development | May 19, 2023 |
Option Exercise | 784,793 |
LH | CEO, Covance Drug Development | May 19, 2023 |
Sale | 932,707 |
LH | CEO, Covance Drug Development | Mar 30, 2023 |
Option Exercise | 648,484 |
LH | CEO, Covance Drug Development | Feb 21, 2023 |
Option Exercise | 547,530 |
LH | CEO, Covance Drug Development | Feb 21, 2023 |
Sale | 2,004,675 |
LH | CEO, Covance Drug Development | Feb 13, 2023 |
Option Exercise | 35,234 |
LH | CEO, Covance Drug Development | Feb 06, 2023 |
Option Exercise | 40,098 |
LH | CEO, Covance Drug Development | Feb 02, 2023 |
Option Exercise | 35,954 |
LH | CEO, Covance Drug Development | Nov 01, 2022 |
Option Exercise | 198,524 |
LH | CEO, Covance Drug Development | Mar 28, 2022 |
Option Exercise | 455,540 |
LH | CEO, Covance Drug Development | Feb 14, 2022 |
Option Exercise | 29,449 |
LH | CEO, Covance Drug Development | Feb 04, 2022 |
Option Exercise | 45,784 |
LH | CEO, Covance Drug Development | Feb 02, 2022 |
Option Exercise | 39,338 |
LH | CEO, Covance Drug Development | Nov 01, 2021 |
Option Exercise | 259,324 |
LH | CEO, Covance Drug Development | Apr 03, 2021 |
Option Exercise | 114,207 |
LH | CEO, Covance Drug Development | Mar 27, 2021 |
Option Exercise | 198,748 |
LH | CEO, Covance Drug Development | Feb 12, 2021 |
Option Exercise | 42,887 |
LH | CEO, Covance Drug Development | Feb 04, 2021 |
Option Exercise | 41,847 |
LH | CEO, Covance Drug Development | Nov 04, 2020 |
Sale | 321,204 |
LH | CEO, Covance Drug Development | Nov 02, 2020 |
Option Exercise | 185,471 |
LH | CEO, Covance Drug Development | Apr 03, 2020 |
Option Exercise | 42,151 |
LH | CEO, Covance Drug Development | Mar 30, 2020 |
Option Exercise | 133,797 |
LH | CEO, Covance Drug Development | Feb 12, 2020 |
Option Exercise | 29,814 |
LH | CEO, Covance Drug Development | Feb 07, 2020 |
Option Exercise | 18,780 |